AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
LIFE

Ethos Technologies Inc. Class A Common Stock (LIFE) fair value

Financial Services · Insurance Brokers · NASDAQ · United States
$43.10-0.99%
Market cap $2.8BNext earnings 2026-11-02Updated Oct 21, 2026
Add earnings to calendarGoogle
Our verdict
Trades 151% above our fair value
Price
$43.10
Model fair valueConfidence: good
$17.19
Model range
$14.77 to $20.66
Fair value $17.19
Price $43.10
3 models fit Ethos Technologies Inc. Class A Common Stock and they partly agree: 2 of 3 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)Silver65
Valued as a growth company: Discounted cash flow, P/E comparison, and EV/EBITDA comparison.
ACCE opinionEthos Technologies Inc. Class A Common Stock (LIFE)
Fair value (3 models)
$17.19
ACCE price target
$34.00
Rating
Overvalued
Horizon
12 months
Fair value published on 21 Oct 2026, 13:04 CEST; previously $18.09 since 17 Oct 2026, 00:00 CEST.
ACCE price target published on 11 Oct 2026, 00:00 CEST.
Rating published on 21 Oct 2026, 13:04 CEST.
Price used: $43.10 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, and EV/EBITDA comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
150.7% above
-60.1% to fair value
ACCE score
58
out of 100
Analysts
89% buy
9 covering
Dividend yield
0.00%

Ethos Technologies Inc. Class A Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Ethos Technologies sells term life insurance directly to consumers online, handling quoting, underwriting and policy issuance through its own platform rather than through agents, and it earns commission-style revenue as a broker and distributor. Revenue grew 113.4% in the latest period, and gross margin of 98.1% reflects how little direct cost sits between a sale and its booked revenue. Operating margin of 9.6% shows the business has reached profitability at the operating line even though return on equity is still negative at -26.1%, which reflects the balance sheet and accounting drag from a company that has only recently started earning. The case rests on whether that growth can keep converting into operating profit as scale builds, which is the question a deeper look needs to answer.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 4 flagsAI-assisted·How I use AI
  • high
    Insider selling outweighs buying
    Last 10 disclosed insider trades total $31.12M in sales against $3.92M in buys. Insiders own 8.7% of shares, so the selling is meaningful.
  • high
    Price well above model fair value
    The stock trades 150.7% above the model fair value of $17.19, and 26.8% above the ACCE price target of $34.00.
  • moderate
    Earnings declining despite revenue surge
    Revenue grew 113.4% year over year while earnings fell 5.3%, and net margin is -18.1% with ROE at -26.1%.
  • moderate
    Score down sharply over 90 days
    The ACCE score fell 8 points, from 66 to 58, over 90 days, with the value sub-score at 30 and quality at 38.

AI research notes

AI-assisted·How I use AIWritten Oct 19, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Revenue grew 113.4% year over year, and has averaged 55.7% growth a year over five years.
  • Free cash flow over the last twelve months came to $30M, so the business is generating real cash.
Why it could disappoint
  • The company still loses money, with a net margin of -18.1% and return on equity of -26.1%.
  • The stock trades 150.7% above the model fair value of $17.19, and only 2 of 3 valuation models were in that consensus.
  • The price implies cash flow growth of 9.4% a year forever, against a free cash flow yield of just 1.2%.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 2, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where LIFE's valuation models land
Price
$43.10
Model fair value
$17.19
Model range
$14.77 to $20.66
Fair value $17.19
Price $43.10
The price is above the whole model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish89% buy · 9 covering analysts
● Strong buy 6● Buy 2● Hold 1● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+14.9%
1 month
+27.1%
3 months
+133.0%
6 months
+157.0%
YTD
no data
1 year
no data

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
21 Oct 2026, 13:04 CESTRatingOvervaluedfirst publication$41.07
21 Oct 2026, 13:04 CESTFair value$17.19$18.09$41.07
17 Oct 2026, 00:00 CESTFair value$18.09$28.63$38.76
11 Oct 2026, 00:00 CESTACCE price target$34.00first publication$36.96
8 Oct 2026, 00:00 CESTFair value$28.63$14.14$35.05
8 Aug 2026, 00:00 CESTFair value$14.14$13.50$30.12
1 Aug 2026, 00:00 CESTFair value$13.50$13.32$20.27
17 Jul 2026, 00:00 CESTFair value$13.32$13.06$18.77
25 Jun 2026, 00:00 CESTFair value$13.06first publication$15.40

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full LIFE page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth64Value30Quality38Momentum100Total58
Valuation
Trailing P/E
no data
Forward P/E
16.4x
PEG
no data
P/B
4.55x
EV / Revenue
3.4x
Book value/sh
$7.47
Enterprise value
$2.0B
Profitability
ROE
-26.1%
FCF yield
1.07%
ROIC
no data
Health and risk
Debt / equity
-0.10
Dividend yield
0.00%
Beta
no data

Price

+155.8% · 1Y

Ask anything about LIFE

Answered from Ethos Technologies Inc. Class A Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
ROEbetter than 17% of peers
low -222%-26%high 176%
Div yieldbetter than 83% of peers
low 0.0%0.0%high 3.4%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
LIFE Ethos Technologies Inc. Class A Common Stock$43.10$17151% above--26.1%3858
AUB.AX AUB Group LimitedA$29.42A$2612% above36.8x6.3%7156
NP Neptune Insurance Holdings Inc. Class A Common Stock$28.44--124.9x0.0%5854
CRVL CorVel Corp. Common Stock$83.87$37129% above37.4x30.7%7866
ARX Accelerant Holdings Class A Common Shares$19.77$2313% below--222.0%6075
GSHD Goosehead Insurance Inc. Class A Common Stock$48.50$3254% above36.9x175.8%6859
BWIN The Baldwin Insurance Group Inc. Class A Common Stock$31.96----10.7%2556

Sector report card

Where LIFE ranks against its sector peers on each metric.

Computing percentiles…
  • GlobeNewswire•Oct 12, 2026
    Ethos to Announce Third Quarter 2026 Financial Results on November 2, 2026
  • Business Wire•Sep 25, 2026
    Baseten Names Sheila Vashee Chief Marketing Officer
  • GlobeNewswire•Aug 19, 2026
    Ethos to Present at the Goldman Sachs Communacopia + Technology Conference
8 more press releases · full archive on Investor+.INVESTOR
40 filings
October 2026
Oct 16
Form 4Insider transactionPeriod 2026-10-15
View on SEC →
Oct 16
Form 4Insider transactionPeriod 2026-10-14
View on SEC →
Oct 9
8-KCurrent reportPeriod 2026-09-30
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR